BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li H, Liu CC, Zheng H, Huang TY. Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer's disease -conformist, nonconformist, and realistic prospects for AD pathogenesis. Transl Neurodegener 2018;7:34. [PMID: 30603085 DOI: 10.1186/s40035-018-0139-3] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Yadav JK. Structural and functional swapping of amyloidogenic and antimicrobial peptides: Redefining the role of amyloidogenic propensity in disease and host defense. J Pept Sci 2021;:e3378. [PMID: 34738279 DOI: 10.1002/psc.3378] [Reference Citation Analysis]
2 Changhong K, Peng Y, Yuan Z, Cai J. Ginsenoside Rb1 protected PC12 cells from Aβ25-35-induced cytotoxicity via PPARγ activation and cholesterol reduction. Eur J Pharmacol 2021;893:173835. [PMID: 33359145 DOI: 10.1016/j.ejphar.2020.173835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Panza F, Lozupone M, Solfrizzi V, Watling M, Imbimbo BP. Time to test antibacterial therapy in Alzheimer's disease. Brain 2019;142:2905-29. [PMID: 31532495 DOI: 10.1093/brain/awz244] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 11.5] [Reference Citation Analysis]
4 Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease. Mol Neurodegener 2020;15:40. [PMID: 32677986 DOI: 10.1186/s13024-020-00391-7] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 35.0] [Reference Citation Analysis]
5 Kaya-Tilki E, Dikmen M. Neuroprotective effects of some epigenetic modifying drugs' on Chlamydia pneumoniae-induced neuroinflammation: A novel model. PLoS One 2021;16:e0260633. [PMID: 34847172 DOI: 10.1371/journal.pone.0260633] [Reference Citation Analysis]
6 Yu H, Wu J. Amyloid-β: A double agent in Alzheimer's disease? Biomed Pharmacother 2021;139:111575. [PMID: 33845371 DOI: 10.1016/j.biopha.2021.111575] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Cheng SY, Cao Y, Rouzbehani M, Cheng KH. Coarse-grained MD simulations reveal beta-amyloid fibrils of various sizes bind to interfacial liquid-ordered and liquid-disordered regions in phase separated lipid rafts with diverse membrane-bound conformational states. Biophys Chem 2020;260:106355. [PMID: 32179374 DOI: 10.1016/j.bpc.2020.106355] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
8 Chatila ZK, Bradshaw EM. Alzheimer's Disease Genetics: A Dampened Microglial Response? Neuroscientist 2021;:10738584211024531. [PMID: 34142603 DOI: 10.1177/10738584211024531] [Reference Citation Analysis]
9 Zhang B, Zhao J, Wang Z, Guo P, Liu A, Du G. Identification of Multi-Target Anti-AD Chemical Constituents From Traditional Chinese Medicine Formulae by Integrating Virtual Screening and In Vitro Validation. Front Pharmacol 2021;12:709607. [PMID: 34335272 DOI: 10.3389/fphar.2021.709607] [Reference Citation Analysis]
10 Fulop T, Tripathi S, Rodrigues S, Desroches M, Bunt T, Eiser A, Bernier F, Beauregard PB, Barron AE, Khalil A, Plotka A, Hirokawa K, Larbi A, Bocti C, Laurent B, Frost EH, Witkowski JM. Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer's Disease. Neuropsychiatr Dis Treat 2021;17:1311-39. [PMID: 33976546 DOI: 10.2147/NDT.S264910] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Kwan P, Konno H, Chan KY, Baum L. Rationale for the development of an Alzheimer's disease vaccine. Hum Vaccin Immunother 2020;16:645-53. [PMID: 31526227 DOI: 10.1080/21645515.2019.1665453] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
12 Lim B, Prassas I, Diamandis EP. Alzheimer Disease Pathogenesis: The Role of Autoimmunity. J Appl Lab Med 2021;6:756-64. [PMID: 33241314 DOI: 10.1093/jalm/jfaa171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Singh RK. Recent Trends in the Management of Alzheimer's Disease: Current Therapeutic Options and Drug Repurposing Approaches. Curr Neuropharmacol 2020;18:868-82. [PMID: 31989900 DOI: 10.2174/1570159X18666200128121920] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
14 Xu S, Yang Z, Zhi Y, Yu S, Zhang T, Jiang J, Tang J, He H, Lu M, Wang X, Wu Q, Zhao X. The effects of antimony on Alzheimer's disease-like pathological changes in mice brain. Science of The Total Environment 2021;760:143235. [DOI: 10.1016/j.scitotenv.2020.143235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Jia L, Piña-Crespo J, Li Y. Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer's disease. Mol Brain 2019;12:104. [PMID: 31801553 DOI: 10.1186/s13041-019-0525-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 14.0] [Reference Citation Analysis]
16 Cendrowska-Pinkosz M, Krauze M, Juśkiewicz J, Ognik K. The effect of the use of copper carbonate and copper nanoparticles in the diet of rats on the level of β-amyloid and acetylcholinesterase in selected organs. J Trace Elem Med Biol 2021;67:126777. [PMID: 33984546 DOI: 10.1016/j.jtemb.2021.126777] [Reference Citation Analysis]
17 Ai PH, Chen S, Liu XD, Zhu XN, Pan YB, Feng DF, Chen S, Xu NJ, Sun S. Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer's disease mice. Transl Neurodegener 2020;9:18. [PMID: 32398165 DOI: 10.1186/s40035-020-00194-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Aliashrafi M, Nasehi M, Zarrindast MR, Joghataei MT, Zali H, Siadat SD. Association of microbiota-derived propionic acid and Alzheimer's disease; bioinformatics analysis. J Diabetes Metab Disord 2020;19:783-804. [PMID: 33553012 DOI: 10.1007/s40200-020-00564-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 Prasanna P, Rathee S, Rahul V, Mandal D, Chandra Goud MS, Yadav P, Hawthorne S, Sharma A, Gupta PK, Ojha S, Jha NK, Villa C, Jha SK. Microfluidic Platforms to Unravel Mysteries of Alzheimer's Disease: How Far Have We Come? Life (Basel) 2021;11:1022. [PMID: 34685393 DOI: 10.3390/life11101022] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, Zhou Z, Shu G, Yin G. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther 2022;7:3. [PMID: 34980884 DOI: 10.1038/s41392-021-00762-6] [Reference Citation Analysis]
21 Sánchez Montero JM, Agis-Torres A, Solano D, Söllhuber M, Fernandez M, Villaro W, Gómez-Cañas M, García-Arencibia M, Fernández-Ruiz J, Egea J, Martín MI, Girón R. Analogues of cannabinoids as multitarget drugs in the treatment of Alzheimer's disease. Eur J Pharmacol 2021;895:173875. [PMID: 33460612 DOI: 10.1016/j.ejphar.2021.173875] [Reference Citation Analysis]
22 Abrahamson EE, Zheng W, Muralidaran V, Ikonomovic MD, Bloom DC, Nimgaonkar VL, D'Aiuto L. Modeling Aβ42 Accumulation in Response to Herpes Simplex Virus 1 Infection: 2D or 3D? J Virol 2020:JVI. [PMID: 33268524 DOI: 10.1128/JVI.02219-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Yuen SC, Zhu H, Leung SW. A Systematic Bioinformatics Workflow With Meta-Analytics Identified Potential Pathogenic Factors of Alzheimer's Disease. Front Neurosci 2020;14:209. [PMID: 32231518 DOI: 10.3389/fnins.2020.00209] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
24 Serafino A, Giovannini D, Rossi S, Cozzolino M. Targeting the Wnt/β-catenin pathway in neurodegenerative diseases: recent approaches and current challenges. Expert Opin Drug Discov 2020;15:803-22. [PMID: 32281421 DOI: 10.1080/17460441.2020.1746266] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Cho BG, Veillon L, Mechref Y. N-Glycan Profile of Cerebrospinal Fluids from Alzheimer's Disease Patients Using Liquid Chromatography with Mass Spectrometry. J Proteome Res 2019;18:3770-9. [PMID: 31437391 DOI: 10.1021/acs.jproteome.9b00504] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
26 Kramer P. Mitochondria-Microbiota Interaction in Neurodegeneration. Front Aging Neurosci 2021;13:776936. [PMID: 35002678 DOI: 10.3389/fnagi.2021.776936] [Reference Citation Analysis]
27 Snow AD, Cummings JA, Lake T. The Unifying Hypothesis of Alzheimer's Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago. Front Aging Neurosci 2021;13:710683. [PMID: 34671250 DOI: 10.3389/fnagi.2021.710683] [Reference Citation Analysis]
28 Tian Y, Meng L, Zhang Z. What is strain in neurodegenerative diseases? Cell Mol Life Sci 2020;77:665-76. [DOI: 10.1007/s00018-019-03298-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
29 Reinscheid F. A new proposal for the causative agent of the sporadic form of Alzheimer's disease. Med Hypotheses 2021;146:110453. [PMID: 33373829 DOI: 10.1016/j.mehy.2020.110453] [Reference Citation Analysis]
30 Frölich L. Alzheimer's disease - the 'microbial hypothesis' from a clinical and neuroimaging perspective. Psychiatry Res Neuroimaging 2020;306:111181. [PMID: 32919870 DOI: 10.1016/j.pscychresns.2020.111181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Murchison AG. Hypothesis: Modulation of microglial phenotype in Alzheimer's disease drives neurodegeneration. Alzheimers Dement 2021. [PMID: 34786841 DOI: 10.1002/alz.12503] [Reference Citation Analysis]
32 Qin L, Xu Q, Li Z, Chen L, Li Y, Yang N, Liu Z, Guo J, Shen L, Allen EG, Chen C, Ma C, Wu H, Zhu X, Jin P, Tang B. Ethnicity-specific and overlapping alterations of brain hydroxymethylome in Alzheimer's disease. Hum Mol Genet 2020;29:149-58. [PMID: 31814020 DOI: 10.1093/hmg/ddz273] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
33 Ouyang Q, Meng Y, Zhou W, Tong J, Cheng Z, Zhu Q. New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease. J Drug Target 2021;:1-21. [PMID: 33983096 DOI: 10.1080/1061186X.2021.1927055] [Reference Citation Analysis]
34 Li D, Liu Y, Zeng X, Xiong Z, Yao Y, Liang D, Qu H, Xiang H, Yang Z, Nie L, Wu PY, Wang R. Quantitative Study of the Changes in Cerebral Blood Flow and Iron Deposition During Progression of Alzheimer's Disease. J Alzheimers Dis 2020;78:439-52. [PMID: 32986675 DOI: 10.3233/JAD-200843] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
35 Wanleenuwat P, Iwanowski P, Kozubski W. Alzheimer's dementia: pathogenesis and impact of cardiovascular risk factors on cognitive decline. Postgrad Med 2019;131:415-22. [PMID: 31424301 DOI: 10.1080/00325481.2019.1657776] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
36 Jamerlan A, An SSA, Hulme J. Advances in amyloid beta oligomer detection applications in Alzheimer's disease. TrAC Trends in Analytical Chemistry 2020;129:115919. [DOI: 10.1016/j.trac.2020.115919] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
37 Liu MM, Liu H, Li SH, Zhong Y, Chen Y, Guo ZZ, Chen W, Lin XH, Lei Y, Liu AL. Integrated paper-based 3D platform for long-term cell culture and in situ cell viability monitoring of Alzheimer's disease cell model. Talanta 2021;223:121738. [PMID: 33298264 DOI: 10.1016/j.talanta.2020.121738] [Reference Citation Analysis]
38 Hou TT, Han YD, Cong L, Liu CC, Liang XY, Xue FZ, Du YF. Apolipoprotein E Facilitates Amyloid-β Oligomer-Induced Tau Phosphorylation. J Alzheimers Dis 2020;74:521-34. [PMID: 32065788 DOI: 10.3233/JAD-190711] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Li F, Hearn M, Bennett LE. The role of microbial infection in the pathogenesis of Alzheimer's disease and the opportunity for protection by anti-microbial peptides. Crit Rev Microbiol 2021;47:240-53. [PMID: 33555958 DOI: 10.1080/1040841X.2021.1876630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Rao CV, Asch AS, Carr DJJ, Yamada HY. "Amyloid-beta accumulation cycle" as a prevention and/or therapy target for Alzheimer's disease. Aging Cell 2020;19:e13109. [PMID: 31981470 DOI: 10.1111/acel.13109] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]